Regulatory T cells but not NKT I cells are modulated by a single low-dose Cyclophosphamide in a B cell lymphoma tumor-model
Aim: Experimental and clinical studies showed that the administration of cyclophosphamide (Cy) in low doses leads to an enhancement of the antitumor immune response. Our objective was to study the modulation, if any, by low dose Cy, of T regulatory (Treg) and natural killer T (NKT) I cells, two cell...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2012 |
| Main Authors: | Rico, M.J., Rozados, V.R., Mainetti, L.E., Zacarias Fluck, M.F., Matar, P., Scharovsky, O.G. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2012
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138719 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Regulatory T cells but not NKT I cells are modulated by a single low-dose Cyclophosphamide in a B cell lymphoma tumor-model / M.J. Rico, V.R. Rozados, L.E. Mainetti, M.F. Zacarias Fluck, P. Matar, O.G. Scharovsky // Experimental Oncology. — 2012. — Т. 34, № 1. — С. 38-42. — Бібліогр.: 36 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
Hodgkin’s lymphoma: the role of cell surface receptors in regulation of tumor cell fate
by: Yurchenko, M., et al.
Published: (2010) -
Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma
by: Andreieva, S.V., et al.
Published: (2017) -
Immunophenotypical features of blastoid variant of mantle cell lymphoma
by: L. M. Skliarenko, et al.
Published: (2019) -
The effect of cytostatics and hyperthermia on RAJI human lymphoma cells
by: Istomin, Yu.Р., et al.
Published: (2011) -
Efficiency of high dose chemotherapy with transplantation of autologous stem cells in patients with prognostically unfavorable variants of hodgkin's lymphoma
by: N. V. Minaeva, et al.
Published: (2008)